Day: February 23, 2026

IS Fyrirtækjalánasjóður hs. er sérhæfður sjóður í rekstri Íslandssjóða hf. Sjóðurinn gaf út skuldabréf sem tekin voru til viðskipta hjá Nasdaq Iceland hf. í nóvember 2024. Meðfylgjandi er ársreikningur sjóðsins fyrir árið 2025.Rekstrarniðurstaða sjóðsins á árinu 2025 var 214 milljónir kr. og eignir sjóðsins námu samtals um 8,4 milljörðum kr. í árslok 2025. Ársreikningurinn var endurskoðaður af KPMG ehf. Það er álit endurskoðanda að ársreikningurinn gefi glögga mynd af afkomu sjóðsins á árinu 2025, fjárhagsstöðu hans 31. desember 2025 og breytingu á handbæru fé á tímabilinu, í samræmi við lög um ársreikninga og lög um rekstraraðila sérhæfðra sjóða.Nánari upplýsingar veitir: Brynjólfur Stefánsson, brynjolfur@islandssjodir.isAttachmentÁrsuppgjör IS 31 12 2025 – IS Fyrirtækjalánasjóður

PRESS RELEASE Arcueil, February 23, 2026 Declaration of transactions on own shares conducted from February 16 to February 20, 2026 Within the framework of the authorizations granted by the General Assembly on February 3, 2026, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from February 16 to February 20, 2026 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2026-02-16 FR0014003U94 4,850 4.1229 XPARAramis Group 9695002Q984W0T41WB42 2026-02-17 FR0014003U94 4,689 4.1760 XPARAramis Group 9695002Q984W0T41WB42 2026-02-18 FR0014003U94 4,769 4.1935 XPARAramis...

Embedding AI in Sonos workflows is creating a new benchmark for efficiency, operational intelligence and risk mitigation NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) — EXL [Nasdaq: EXLS], a global data and AI company, today announced a critical transformation initiative with Sonos (Nasdaq: SONO), the world’s leading sound experience company, and Amazon Web Services (AWS). This unique collaboration deploys agentic AI within Sonos IT service management (ITSM) workflows, aiming to create a new benchmark for efficiency, operational intelligence and risk mitigation. The initiative brings together Sonos innovative culture, EXL’s deep expertise in AI-led solutions and the powerful cloud infrastructure of AWS. The initiative represents a significant step forward in applying sophisticated AI to real-world enterprise scenarios. By harnessing...

LONDON and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that its abstract has been accepted for presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting, taking place May 3-7, 2026, in Denver, Colorado. Chief Scientific Officer Raj Patil, Ph.D., will share the data in a presentation titled: “First-in-Human Study of Urcosimod to Treat Neuropathic Corneal Pain (NCP) Shows Clinically Meaningful Pain Reduction and Quality-of-Life Improvement in NCP Patients.” This presentation highlights positive results from OKYO’s recently completed proof-of-concept Phase 2a...

ATHENS, Greece, Feb. 23, 2026 (GLOBE NEWSWIRE) —  Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of vessels, announced today that it has entered into an agreement with Central Mare Inc, an affiliate of Mr. Evangelos Pistiolis, (“the Seller”), to acquire 100% of the issued and outstanding shares of a Marshall Islands company (the “SPV”), counterparty to a ship building contract for a very-high specification 47,499 dwt Medium Range (“MR”) product/chemical oil tanker with Guangzhou Shipyard International Company Limited, scheduled for delivery during 2029. The ship building contract effectiveness is subject to the issuance of a customary refund guarantee and the acquisition of the SPV is subject to conclusion of financing arrangements. Specifically,...

Appointments add decades of defense, security, and international program experience to T3 Defense’s executive team NEW YORK and TEL AVIV, Israel, Feb. 23, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (NASDAQ: DFNS),  a strategic acquirer and developer of high-potential businesses in the Aerospace and Defense (A&D) sector, formerly Nukkleus Inc., today announced two senior leadership appointments aimed at strengthening execution, scalability, and long-term production reliability. T3 Defense appointed Emil Blumer as Chief Business Officer and Jordan Buchler as Chief Executive Officer of its Manufacturing & Industrial Processing Division, aligning commercial growth and operational execution around the industrial capabilities that most directly influence production continuity. As Chief Business Officer, Mr. Blumer is responsible...

DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) — Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar oncology deals and accelerating immunotherapy revenues, today’s tape reflects capital flowing toward platforms with validation. Kraig Biocraft Laboratories Featured on National Geographic Cover Shares of Kraig Biocraft Laboratories (OTCQB:KBLB) could see elevated interest after the company’s recombinant spider silk technology landed on the cover of the March 2026 issue of National Geographic.The feature, The Quest for Spider Silk, spotlighted Kraig’s genetically enhanced silkworm platform, engineered to spin recombinant spider silk as part of the animal’s natural biological process. The coverage included facility tours and demonstrations...